Zumiez (ZUMZ) executive details December 2025 option exercises and share sales
Rhea-AI Filing Summary
Zumiez Inc executive Chris K. Visser, Chief Legal Officer and Secretary, reported exercising stock options and selling the related common shares in December 2025. On December 9, 2025, he exercised 727 options at $24.54 and sold 727 shares of common stock at a weighted average price of $30.25. On December 15, 2025, he exercised 1,884 options at $24.54 and 8,159 options at $18.6, then sold 8,159 shares at a weighted average price of $29.3946 and 1,884 shares at a weighted average price of $29.1185. After these transactions, he directly owned 44,303 Zumiez common shares.
Positive
- None.
Negative
- None.
FAQ
What insider activity did Zumiez (ZUMZ) report in this Form 4?
The report shows that Chris K. Visser, Zumiez’s Chief Legal Officer and Secretary, exercised stock options and sold the corresponding shares of common stock in December 2025.
On what dates did the Zumiez (ZUMZ) executive trade shares and options?
The reported transactions occurred on December 9, 2025 and December 15, 2025, covering both stock option exercises and sales of Zumiez common stock.
How many Zumiez (ZUMZ) shares did Chris K. Visser own after the transactions?
Following the reported option exercises and share sales, Chris K. Visser directly owned 44,303 shares of Zumiez Inc common stock.
What option exercise prices were involved in the Zumiez (ZUMZ) Form 4?
The stock options exercised had exercise prices of $24.54 and $18.6 per share, with the underlying securities being Zumiez common stock.
At what prices were the Zumiez (ZUMZ) shares sold in these insider transactions?
Shares were sold at weighted average prices of $30.25 on December 9, 2025, and $29.3946 and $29.1185 on December 15, 2025, as disclosed in the report.
Were the Zumiez (ZUMZ) share sales related to stock option exercises?
Yes. The Form 4 shows transaction code M for stock option exercises followed by code S sales of the same number of Zumiez common shares on the respective dates.